Exact peptide identities attached to retained registry observations carrying this condition label.
Coverage-gated living condition brief
Chronic Kidney Disease peptide evidence brief
A cited Chronic Kidney Disease peptide evidence brief across 23 exact-label ClinicalTrials.gov records, 9 connected profiles, and 9 registry-update years. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
23 selected records.
9 profiles.
2012–2026 in selected records.
Direct collection answer · published August 17, 2026
What peptide evidence does PeptideScanner carry for Chronic Kidney Disease?
PeptideScanner’s selected collection contains 23 retained ClinicalTrials.gov records carrying the exact condition label “Chronic Kidney Disease,” connected to 9 peptide profiles across 9 registry-update years.
That answer describes this collection and the exact cited registry observations below. It is not a conclusion about whether any peptide treats Chronic Kidney Disease, and it is not a safety or efficacy assessment.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 271 selected PubMed records and 42 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Chronic Kidney Disease unless their own cited source says so.
Related profile context
Literature connected through these peptide profiles
This is a bounded sample of up to six PubMed bibliography records connected through peptide profiles on this hub, not the total profile literature count above. They are not condition-matched records, and their presence does not establish that they concern Chronic Kidney Disease.
Peginesatide · source record 2026-11-09
Peginesatide acetate, axitinib, and pertuzumab.
PubMed lists PMID 23023854 in Journal of the American Pharmacists Association : JAPhA as Journal Article, Review, with publication-date metadata of 2012 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Etelcalcetide · source record 2026-10-31
Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study.
PubMed lists PMID 36790677 in International urology and nephrology as Observational Study, Journal Article, with publication-date metadata of 2023-02-15 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Semaglutide · source record 2026-11-12
Semaglutide and alcohol use disorder: An evidence gap India must fill.
PubMed lists PMID 43011941 in Indian journal of psychiatry as Letter, with publication-date metadata of 2026-10-21 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Daptomycin · source record 2026-11-09
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial.
PubMed lists PMID 32725216 in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Equivalence Trial, with publication-date metadata of 2021-05-04 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →MK-677 · source record 2026-01-27
LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report.
PubMed lists PMID 36303408 in Experimental physiology as Case Reports, Research Support, Non-U.S. Gov't, Journal Article, with publication-date metadata of 2022-11-16 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Orforglipron · source record 2026-11-09
Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight.
PubMed lists PMID 41994902 in Diabetes, obesity & metabolism as Clinical Trial, Phase I, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00097747
PeptideScanner retained ClinicalTrials.gov record NCT00097747 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 21, 2012
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00228436
PeptideScanner retained ClinicalTrials.gov record NCT00228436 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 21, 2012
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00228449
PeptideScanner retained ClinicalTrials.gov record NCT00228449 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 21, 2012
- Evidence lane
- Clinical trials
Exact-record source chronology
Chronic Kidney Disease registry timeline
Years come from the last-update date on each retained ClinicalTrials.gov observation. They show source chronology, not when PeptideScanner added the record and not a continuous monitoring guarantee.
2026
7 recordsAmycretin · 2026-11-12
ClinicalTrials.gov record NCT07931547
Not yet recruiting at the retained observation.
Open cited registry record →Orforglipron · 2026-11-04
ClinicalTrials.gov record NCT07241390
Recruiting at the retained observation.
Open cited registry record →Semaglutide · 2026-10-28
ClinicalTrials.gov record NCT07900438
Recruiting at the retained observation.
Open cited registry record →Semaglutide · 2026-10-13
ClinicalTrials.gov record NCT07547878
Enrolling by invitation at the retained observation.
Open cited registry record →Semaglutide · 2026-10-05
ClinicalTrials.gov record NCT07858331
Not yet recruiting at the retained observation.
Open cited registry record →Tirzepatide · 2026-09-11
ClinicalTrials.gov record NCT05536804
Completed at the retained observation.
Open cited registry record →Etelcalcetide · 2026-02-27
ClinicalTrials.gov record NCT03633708
Recruiting at the retained observation.
Open cited registry record →2024
1 recordApraglutide · 2024-10-26
ClinicalTrials.gov record NCT04699032
Completed at the retained observation.
Open cited registry record →2021
1 recordEtelcalcetide · 2021-04-30
ClinicalTrials.gov record NCT03299244
Completed at the retained observation.
Open cited registry record →2019
2 recordsEtelcalcetide · 2019-07-18
ClinicalTrials.gov record NCT01896232
Completed at the retained observation.
Open cited registry record →Peginesatide · 2019-03-14
ClinicalTrials.gov record NCT00314795
Completed at the retained observation.
Open cited registry record →2018
1 recordDaptomycin · 2018-06-06
ClinicalTrials.gov record NCT01012089
Completed at the retained observation.
Open cited registry record →2017
1 recordMK-677 · 2017-02-20
ClinicalTrials.gov record NCT00395291
Completed at the retained observation.
Open cited registry record →2016
1 recordPeginesatide · 2016-09-20
ClinicalTrials.gov record NCT01478971
Completed at the retained observation.
Open cited registry record →2013
4 recordsPeginesatide · 2013-03-08
ClinicalTrials.gov record NCT00597584
Completed at the retained observation.
Open cited registry record →Peginesatide · 2013-02-12
ClinicalTrials.gov record NCT00597753
Completed at the retained observation.
Open cited registry record →Peginesatide · 2013-02-12
ClinicalTrials.gov record NCT00598273
Completed at the retained observation.
Open cited registry record →Peginesatide · 2013-02-12
ClinicalTrials.gov record NCT00598442
Completed at the retained observation.
Open cited registry record →2012
5 recordsPeginesatide · 2012-12-21
ClinicalTrials.gov record NCT00097747
Completed at the retained observation.
Open cited registry record →Peginesatide · 2012-12-21
ClinicalTrials.gov record NCT00228436
Completed at the retained observation.
Open cited registry record →Peginesatide · 2012-12-21
ClinicalTrials.gov record NCT00228449
Completed at the retained observation.
Open cited registry record →Peginesatide · 2012-06-29
ClinicalTrials.gov record NCT00434330
Completed at the retained observation.
Open cited registry record →Peginesatide · 2012-06-29
ClinicalTrials.gov record NCT00680043
Completed at the retained observation.
Open cited registry record →- Condition matching is limited to exact labels on retained ClinicalTrials.gov v3 observations; PeptideScanner does not merge related diagnoses or synonyms.
- Coverage is selective and historical, not a complete or continuously current account of the registry or PubMed.
- The brief does not synthesize study outcomes, compare interventions, or make safety, efficacy, diagnosis, or treatment claims.